Clinical Trials Logo

Fistula clinical trials

View clinical trials related to Fistula.

Filter by:

NCT ID: NCT01696903 Completed - Pancreatic Fistula Clinical Trials

Evaluation of a Novel Pancreaticojejunostomy Technique for Pancreaticoduodenectomy

Start date: September 2011
Phase: N/A
Study type: Interventional

Pancreaticoduodenectomy is a surgical procedure for removing cancer in the pancreas, the bile system or the duodenum that is associated with a high rate of complications. The study wants to investigate whether a new technique to reconstruct the joint between the pancreatic gland and the short bowel can reduce the rate of severe complications after this complex surgical procedure.

NCT ID: NCT01693263 Active, not recruiting - Dialysis Clinical Trials

Outcome of BCF Access in Hemodialysis Patients

BCF
Start date: October 2011
Phase:
Study type: Observational

Dialysis access, which is the connection that allows blood to flow in and out of the body during dialysis sessions, is important to remove wastes and excess fluid for patients with end stage renal disease (ESRD). One method used to access the vein and artery for dialysis is called a brachiocephalic fistula. Patients are being asked to participate in this study because they have endstage renal disease, and their doctor has recommended that they will have brachiocephalic fistula placed for their dialysis access. A common problem seen in patients with a brachiocephalic fistula (BCF) is cephalic arch stenosis (CAS). CAS is a narrowing in the central vein (located in the upper chest). CAS causes problems with the opening of the veins and arteries needed for dialysis. Once someone suffers CAS they may need several radiology procedures as well as surgery to help correct the problem. The BCF may fail once CAS develops. The purpose of the research study is to gather information about the BCF and what is happening inside the vein. The researchers hope to find out what may be the cause of CAS.

NCT ID: NCT01672593 Recruiting - Clinical trials for Low-output External Gastrointestinal Fistula

Glue Sealing for Patients With Low-Output ECFs

Glue-sealing
Start date: May 2012
Phase: N/A
Study type: Interventional

Adjuvant use of fibrin glue (FG) in the fistula tract has been shown to promote closure of low-output ECFs. The primary objectives of this study are to compare the clinical efficacy, safety of autologous platelet-rich fibrin glue (PRFG) and a commercially available fibrin sealant Bioseal® in the management of patients with low-output volume ECFs.

NCT ID: NCT01669850 Terminated - Clinical trials for Arteriovenous Fistula Complications and Failure

Clipped Versus Handsewn Arteriovenous Fistula Anastomosis

Start date: August 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether handsewn anastomosis versus clipped technique is associated with more complications, fistula failures, surgical cost and surgical time.

NCT ID: NCT01656486 Completed - Pancreatic Fistulae Clinical Trials

Stereotactic Radiation to Decrease Pancreatic Secretions

Start date: July 2012
Phase: N/A
Study type: Interventional

Patients that have undergone pre-operative radiation for pancreatic carcinoma, that upon pathologic examination of the normal portion of the pancreatic gland that was in the radiation field showed acute and chronic changes in the pancreatic cells. The hypothesis for utilizing stereotactic radiation on pancreatic fistulae is that the treatment will decrease pancreatic secretions, thus decreasing autodigestion.

NCT ID: NCT01646788 Not yet recruiting - Clinical trials for Obstructive Lesions of Arteriovenous Dialysis Fistulae

Study of NMB Drug Ejecting Balloon for Arteriovenous Fistulae

Start date: January 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to demonstrate the safety and effectiveness of the use of NMB's percutaneous transluminal angioplasty (PTA) for the treatment of obstructive lesions of Arteriovenous (AV) Dialysis Fistulae/Grafts.

NCT ID: NCT01642459 Terminated - Clinical trials for Arteriovenous Fistula

The Outcomes of Arteriovenous Fistula Cannulated From Different Direction.

Start date: September 2012
Phase: N/A
Study type: Interventional

The investigators hypothesis that aneurysms and stenoses will be decreased if the direction of inserted arterial needle were same as the direction of blood flow, when compared to the opposite direction puncture.

NCT ID: NCT01635543 Withdrawn - Crohn's Disease Clinical Trials

Investigation of Sexual Function in Crohn's Disease Patients With Perianal Fistulas

Start date: October 2011
Phase: N/A
Study type: Observational

Objective: The aim of this study is to investigate whether Crohn's Disease patients with peri-anal fistulas will suffer from sexual dysfunction in an attempt to help us identify Crohn's Disease patients that would benefit from sexual health interventions. Hypothesis: Crohn's patients with active perianal fistulas will have decreased sexual drive, performance, and satisfaction than those with Crohn's Disease in remission.

NCT ID: NCT01624350 Completed - Anorectal Fistulas Clinical Trials

A Prospective, Multi-center, Observational Study of the Use of Permacolâ„¢ Collagen Paste to Treat Anorectal Fistulas

Start date: September 2012
Phase: N/A
Study type: Observational

This will be a prospective, multi-center, post-market, single arm observational study to collect clinical outcome data on the use of Permacolâ„¢ Collagen Paste in the treatment of anorectal fistulas. The subjects will have baseline and day of surgery visits performed, and then subjects will return to the investigator for evaluation of defect and safety related morbidities at follow up visits scheduled at 1 month, 3 months, 6 months and 12 months post-surgery.

NCT ID: NCT01623453 Terminated - Perianal Fistula Clinical Trials

Follow-up Study of Autologous Adipose-derived Stem Cells (ANTG-ASC) for the Complex Fistula (ANTG-ASC-211)

ANTG
Start date: September 2010
Phase: N/A
Study type: Observational

This is an open follow-up clinical trial to evaluate a sustained efficacy and safety of ANTG-ASC injection for 4 months (6 months after final dose injection) after Phase II clinical trial.